We currently have two post-doctoral positions for those interested in studying how niche factors can be converted into drugs to prevent leukemic evolution and inflammation-induced HSC damage. Please DM or email [email protected] to find out more!
Please join us in congratulating Dr. Nirali Shah @NiraliShahMD on receiving a @CCFtoday grant award for research in B-cell acute lymphoblastic leukemia. Learn more here: https://childrenscancerfoundation.org/the-childrens-cancer-foundation-inc-announces-the-2022-ccf-research-awards/ @NCI_CCR_PedOnc #CCRNews #PediatricOncology
Thanks to @ScienceMagazine for highlighting our work. My longest, hardest, and (hopefully) most impactful project. Stay tuned for the paper!
Single-cell studies offer new view of how HIV infections persist—and might be cured https://www.science.org/content/article/single-cell-studies-offer-new-view-how-hiv-infections-persist-and-might-be-cured#.YvCISFevKOc.twitter
Nice detailed work from the @NIH POB on a bicistronic CD19.CD22 CAR-T clinical product. The little details matter @BloodJournal @HighfillSteven @NCI_CCR_PedOnc @NCIResearchCtr https://ashpublications.org/blood/article-abstract/140/5/451/485318/CD19-22-CAR-T-cells-in-children-and-young-adults?redirectedFrom=fulltext
It was a pleasure to meet w/MOH Hon Sethomo Lelatisitswe at #AIDS2022 to talk about @BWGovernment surpassing 95-95-95 #HIV treatment target! This is an incredible achievement & one step closer to ending HIV/AIDS as a public health threat. #EndAIDS2030
🔗https://go.usa.gov/xSAEP
Veteran #HIV researcher and clinician Dr. Steven Deeks will receive the 2022 Lifetime Achievement in Mentoring Award from @UCSF's Faculty Mentoring Program this Friday, Aug 12 https://fal.cn/3qRlY
Today @nih_nhlbi kicks off its Annual #SCD Research Meeting! This event virtually gathers health care providers, warriors, and advocates to discuss progress in #SCD clinical trials and studies over three days. Register here to virtually attend: https://bit.ly/3SbiFby
Dr Fitzhugh @nih_nhlbi presented clear rationale at the SCD meeting for deep sequencing for #SCD prior to gene therapy as risk assessment for clonal hematopoiesis @NHLBI_BLOODDir mutations found are standard and could be developed as a low cost test @ConquerSCD @SickleInAfrica
For those asking what I’d like for my birthday, please consider donating to @TentAbrahams, which is opening a school in #Guyana & providing college scholarships to HS students in the USA. Learn more at http://www.abrahamstentinc.org. Invest in future leaders with me & @PamSharmaMDPhD
At #AIDS2022, @wizara_afyatz's Prof. Abel Makubi and I had a good discussion about #PEPFAR, sustainability, and the Tanzania Ministry of Health’s prioritizing improved program quality.
Our latest whitepaper by the Hon. Dr Mark Dybul has been published- please visit our site and get the free download of “Global Access to Human Gene Therapy: Lessons Learned from HIV” #AIDS2022 @DAREtoCureHIV @CureHIVNOW @UNAIDS @amfAR @defeatHIV @HIVGov https://caringcross.org/whitepapers/
@JNkengasong opens the @PEPFAR Annual Meeting with the plan for reimagining PEPFAR with fundamental values of humility/respect, #equity & accountability. Exciting to see the call to scale up #behavioral & #impsci & #socialscience to bend the curve on new infections #AIDS2022
New report of a bone transplant transplant approach yielding a true cure to HIV. We are so excited to see these advances, and look for way to bring them to all. @amfAR @DAREtoCureHIV @defeatHIV #IAS22 @AIDS_conference #AIDS2022 https://www.bbc.com/news/health-62312249.amp
India has had a decent success with our #HIV programs and public health efforts. Drug stockouts at this juncture could derail some of this.
This needs action now. The #PLHIV communities needs our support. They have a right to demand steady supply of ARVs https://twitter.com/tabassum_b/status/1551486923557900288
Indefinite protest by HIV patients continues outside NACO. Patients are camping outside the office day and night demanding antiretroviral drugs. Yesterday Delhi police was called to move the patients. The plight this time is worst in recent years @scroll_in
In celebration of World #SickleCell Day last month, @SCAGO1 hosted a training session on conducting #global #advocacy for #SCD. In this session, panelists shared how to get your voices heard at all levels of government. Check out the recording here: https://bit.ly/3OPhYm7
Read our exclusive interview with Prof Rimas Orentas Seattle Children's Research Institute, on what happens when we activate chimeric antigen receptor (CAR) T cells.
➡️ https://bit.ly/3OmKaeU
@caring_cross @UW
#Researcher #immunology
Nicely done @khanjavNCI @MitchellHo a great combo CAR! @NCIResearchCtr https://www.jci.org/articles/view/155621/version/1
Thanks to Dr. Marcos de Lima from @OhioState for presenting at our July 15 event entitled: Local manufacture of anti CD19 CAR T cells to treat non-Hodgkin’s lymphoma.
You may watch the video in our Members area. If you're not a member yet, register here: https://caringcross.org/become-a-member/
